Accessibility Menu
Bio-Techne logo

Bio-Techne

(NASDAQ) TECH

Current Price$70.84
Market Cap$11.09B
Since IPO (1992)+13,155%
5 Year-36%
1 Year+34%
1 Month+42%

Bio-Techne Financials at a Glance

Market Cap

$11.09B

Revenue (TTM)

$1.21B

Net Income (TTM)

$109.57M

EPS (TTM)

$0.70

P/E Ratio

101.74

Dividend

$0.32

Beta (Volatility)

1.15 (Average)

Price

$70.84

Volume

7,826,274.709

Open

$70.90

Previous Close

$70.83

Daily Range

$70.65 - $71.00

52-Week Range

$43.20 - $72.16

Estimated Earnings Date

Aug 5, 2026

TECH: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Techne

Industry

Life Sciences Tools and Services

Employees

3,100

CEO

Kim Kelderman

Headquarters

Minneapolis, MN 55413, US

TECH Financials

Key Financial Metrics (TTM)

Gross Margin

64.96%

Operating Margin

12.70%

Net Income Margin

9.05%

Return on Equity

5.49%

Return on Capital

4.33%

Return on Assets

4.30%

Earnings Yield

0.98%

Dividend Yield

0.45%

Payout Ratio

45.47%

Stock Overview

Market Cap

$11.09B

Shares Outstanding

156.57M

Volume

7.83M

Avg. Volume

4.40M

Financials (TTM)

Gross Profit

$786.49M

Operating Income

$153.75M

EBITDA

$257.98M

Operating Cash Flow

$294.86M

Capital Expenditure

-$25.26M

Free Cash Flow

$269.60M

Cash & ST Invst.

$209.82M

Total Debt

$290.32M

Bio-Techne Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$311.42M

-1.5%

Gross Profit

$208.29M

-2.9%

Gross Margin

66.88%

N/A

Market Cap

$11.09B

N/A

Market Cap/Employee

$3.58M

N/A

Employees

3,100

N/A

Net Income

$51.06M

+126.0%

EBITDA

$98.62M

+45.3%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$209.82M

+49.2%

Total Debt

$290.32M

-31.4%

Accounts Receivable

$217.92M

-8.1%

Inventory

$201.18M

+5.3%

Long Term Debt

$276.14M

-32.6%

Short Term Debt

$14.18M

+0.9%

Return on Assets

4.30%

N/A

Return on Invested Capital

6.41%

N/A

Free Cash Flow

$77.58M

+150.3%

Operating Cash Flow

$86.66M

+110.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BMRNBioMarin Pharmaceutical Inc.
$58.99+2.02%
MDGLMadrigal Pharmaceuticals, Inc.
$528.10+2.67%
CORTCorcept Therapeutics Incorporated
$90.21+1.96%
QGENQiagen N.V.
$40.10+2.48%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$20.58+0.00%
INTCIntel
$120.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About TECH

What is the current price of Bio-Techne?

Bio-Techne is trading at $70.83 per share.

What is the 52-week range for Bio-Techne?

Over the past 52 weeks, Bio-Techne has traded between $43.20 and $72.16.

How much debt does Bio-Techne have?

As of the most recent reporting period, Bio-Techne reported total debt of $290.32M.

How much cash does Bio-Techne have on hand?

Bio-Techne reported $209.82M in cash and cash equivalents in its most recent financial results.

What is Bio-Techne’s dividend yield?

Bio-Techne currently has a dividend yield of 0.45%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.